Bridging the Diagnostic Gap for Hypermobile Ehlers‐Danlos Syndrome and Hypermobility Spectrum Disorders: Evidence of a Common Extracellular Matrix Fragmentation Pattern in Patient Plasma as a Potential Biomarker
American Journal of Medical Genetics Part A · 2025-01 · 197 (1)
DOI: 10.1002/ajmg.a.63857 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Medical Genetics Part A, online erschienen am 03.09.2024. Verfasst von Marco Ritelli und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Biology and Genetics, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy. Hauptthemen laut MEDLINE: Ehlers-Danlos Syndrome, Biomarkers, Joint Instability, Extracellular Matrix. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ehlers-Danlos Society.
Abstract (Originalsprache)
Diagnosing hypermobile Ehlers‐Danlos syndrome (hEDS) and hypermobility spectrum disorders (HSD), common overlapping multisystemic conditions featuring symptomatic joint hypermobility, is challenging due to lack of established causes and diagnostic tools. Currently, the 2017 diagnostic criteria for hEDS are used, with non‐qualifying cases classified as HSD, although the distinction remains debated. We previously showed extracellular matrix (ECM) disorganization in both hEDS and HSD dermal fibroblasts involving fibronectin (FN), type I collagen (COLLI), and tenascin (TN), with matrix metalloproteinase‐generated fragments in conditioned media. Here, we investigated these fragments in patient plasma using Western blotting across diverse cohorts, including patients with hEDS, HSD, classical EDS (cEDS), vascular EDS (vEDS), rheumatoid arthritis (RA), psoriatic arthritis (PsA), and osteoarthritis (OA), and healthy donors, uncovering distinctive patterns. Notably, hEDS/HSD displayed a shared FN and COLLI fragment signature, supporting their classification as a single disorder and prompting reconsideration of the hEDS criteria. Our results hold the promise for the first blood test for diagnosing hEDS/HSD, present insights into the pathomechanisms, and open the door for therapeutic trials focused on restoring ECM homeostasis using an objective marker. Additionally, our findings offer potential biomarkers also for OA, RA, and PsA, advancing diagnostic and therapeutic strategies in these prevalent joint diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Biology and Genetics, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.
- Rheumatology and Clinical Immunology Unit, Department of Clinical and Experimental Sciences, ASST Spedali Civili and University of Brescia, European Reference Network on Rare and Complex Connective Tissue and Musculoske…
- Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.
- Orthopedics and Traumatology Unit, Manerbio Hospital, ASST Garda, Brescia, Italy.
- The Ehlers-Danlos Society, New York, New York, USA.
- Division of Dermatology, Department of Clinical and Experimental Sciences, ASST Spedali Civili and University of Brescia, European Network for Rare Skin Disorders (ERN-Skin), Brescia, Italy.
ORCID-Profile: Marco Ritelli, Valeria Cinquina, Marina Colombi
Förderung
- Ehlers-Danlos Society
Zitieren
APA
Ritelli, M., Chiarelli, N., Cinquina, V., Bertini, V., Piantoni, S., Caproli, A., Della Pina, S. E. L., Franceschini, F., Zarattini, G., Gandy, W., Venturini, M., Zoppi, N., & Colombi, M. (2025). Bridging the Diagnostic Gap for Hypermobile Ehlers‐Danlos Syndrome and Hypermobility Spectrum Disorders: Evidence of a Common Extracellular Matrix Fragmentation Pattern in Patient Plasma as a Potential Biomarker. American Journal of Medical Genetics Part A, 197(1). https://doi.org/10.1002/ajmg.a.63857
Vancouver
Ritelli M, Chiarelli N, Cinquina V, Bertini V, Piantoni S, Caproli A, et al. Bridging the Diagnostic Gap for Hypermobile Ehlers‐Danlos Syndrome and Hypermobility Spectrum Disorders: Evidence of a Common Extracellular Matrix Fragmentation Pattern in Patient Plasma as a Potential Biomarker. American Journal of Medical Genetics Part A. 2025;197(1). doi:10.1002/ajmg.a.63857
BibTeX
@article{Ritelli2025,
author = {Ritelli, Marco and Chiarelli, Nicola and Cinquina, Valeria and Bertini, Valeria and Piantoni, Silvia and Caproli, Alessia and Della Pina, Silvia Ebe Lucia and Franceschini, Franco and Zarattini, Guido and Gandy, Woodrow and Venturini, Marina and Zoppi, Nicoletta and Colombi, Marina},
title = {Bridging the Diagnostic Gap for Hypermobile Ehlers‐Danlos Syndrome and Hypermobility Spectrum Disorders: Evidence of a Common Extracellular Matrix Fragmentation Pattern in Patient Plasma as a Potential Biomarker},
journal = {American Journal of Medical Genetics Part A},
year = {2025},
volume = {197},
number = {1},
doi = {10.1002/ajmg.a.63857}
}
EUVIMED